期刊文献+

重组水蛭素鼻腔喷雾剂及辅料的鼻黏膜毒性评价 被引量:4

Studies on the nasal epithelium toxicity of adjuvants and recombination hirudin (rHV2) nasal spary
下载PDF
导出
摘要 目的:考察重组水蛭素鼻腔喷雾剂及其辅料的鼻黏膜毒性作用。方法:采用在体蟾蜍上腭模型法,光学显微镜下观察纤毛持续运动时间,考察辅料和重组水蛭素的纤毛毒性作用;采用病理学检查法考察长期给予家兔重组水蛭素鼻腔喷雾剂对鼻黏膜结构的影响。结果和结论:辅料SDS,Brij35,azone,lecithin,EDTA,menthol,ni-pagin,thiomersal可显著抑制纤毛运动(与PRS组比较P<0.05),而HP-β-CD,tween80,甘草酸单胺盐,benzalkoniumbromide,sodiumbenzoate及黏附性材料对纤毛运动影响较小;重组水蛭素鼻腔喷雾剂长期给药对鼻黏膜结构有一定影响,但此作用可在停止给药后恢复。表明辅料SDS,Brij35,azone,lecithin,EDTA,menthol,nipagin,thiomersal等的纤毛毒性较大;而HP-β-CD,tween80,甘草酸单胺盐,benzalkoniumbromide,sodiumbenzoate及黏附性材料的纤毛毒性较小,可用于鼻腔给药;黏附性材料壳聚糖可能会加重某些辅料的纤毛毒性;重组水蛭素鼻腔给药具有可行性。 Objective: To investigate the nasal epithelium toxicity of adjuvants and rHV2 nasal spary(HVS) . Method: Ciliary movement were evaluated with in situ toad palate model; The histology assessment of nasal epithelium were carried out after long-lasting and repeated use of HVS. Result and conclusion: Adjuvants included SDS, Brij 35, azone, lecithin, EDTA, menthol, nipagin and thiomersal were able to significantly inhibited the ciliary movement, while tween80, glycyrrhizic acid monoammonium salt, benzalkonium bromide,sodium benzoate and adhensive materials investigated had less influence on it. HVS was able to damaged the nasal epithelium, but this effect recovered soon after sloping administration. It was demonstrated that SDS, Brij 35, azone, lecithin, EDTA, menthol, nipagin and thiomersallt had significant cilitoxity, while tween80,glycyrrhizic acid monoammonium salt, benzalkonium bromide, sodium benzoate and adhensive materials investigated had no significance; Chitosan co-administration with some adjuvants may make the cillitoxity severer; It is available that rHV2 be administered by nasal spary.
出处 《中国中药杂志》 CAS CSCD 北大核心 2005年第11期821-824,共4页 China Journal of Chinese Materia Medica
关键词 重组水蛭素 鼻黏膜毒性 吸收促进剂 纤毛运动 生物黏附材料 鼻腔喷雾剂 中药 recombination hirudin nasal epithelium toxity absorption enhancers ciliary movement adhensive materials nasal spary
  • 相关文献

参考文献13

二级参考文献47

  • 1蒋新国,崔景斌,方晓玲,韦阳,奚念朱.药物的鼻粘膜纤毛毒性及评价方法[J].药学学报,1995,30(11):848-853. 被引量:86
  • 2陆翔 蒋新国 等.促进剂对大鼠鼻粘膜药物吸收的影响[J].上海医科大学学报,1996,23:49-49.
  • 3[1]Markwardt F. The development of hirudin as an antithrombotic drug. Thrombosis Research, 1994,74( 1 ): 1 ~ 23.
  • 4[2]Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Heamost, 1991 ;66(1 ): 141 ~ 152.
  • 5[3]Vindigni V, Filippis VD, Zanotti G, et al. Probing the structure of hirudin from hirudinaria manillensis by limited proteolysis: isolation, characterization and thrombin-inhibitory properties of N-terminal fragments. Eur J Biochem,1994,226: 323 ~ 333.
  • 6[5]Nowak G, Markwardt F. Hirudin in disseminated intravascular coagulation.Haemostasis, 1991,21 (Supple 1 ): 142 ~ 148.
  • 7[6]Markwardt F, Kaiser B, Nowak G. Studies on antithrombotic effects of recombinant hirudin. Thromb Res, 1989,54(5) :377 ~ 388.
  • 8[7]Zawilska K, Zozulinska M, Turowiecka Z, et al. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIG) in rabbits. Thromb Res, 1993,69(3): 315 ~ 320.
  • 9[8]Doutremepuich C, Deharo E, Guyot M, et al. Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparin. Thromb Res,1989,54(5) :435 ~ 445.
  • 10[9]Talbot MD, Ambler I, Butler KD, et al. Recombinant desulphato-hirudin (CGP39393): anticoagulant and antithrombotic properties in vivo. Thromb Hemost, 1989,61 ( 1 ): 77 ~ 80.

共引文献218

同被引文献84

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部